Retatrutide 30mg Self Mix is an advanced weight management peptide used to reduce appetite, improve satiety, and support fat loss. It is for people who want better hunger control, better control over food intake, and more consistent fat-loss progress, using traditional peptide mixing and insulin syringe dosing. Supplied as a 30 mg vial for self-mixing, it offers the same high-strength format in a conventional injectable setup.
How It Works
Retatrutide works by acting on three metabolic pathways involved in appetite control, satiety, and energy use. This helps reduce hunger, improve control over food intake, and support a stronger fat-loss response over time.
| Pathway |
Effect |
| GLP-1 |
Helps reduce appetite and improve satiety |
| GIP |
Supports metabolic regulation |
| Glucagon |
Supports increased energy expenditure and fat-loss activity |
Research Findings
Research on Retatrutide has shown meaningful effects on appetite reduction, body-weight reduction, and metabolic control. Outcomes have been dose-dependent, with stronger effects seen as dosing is increased over time.
| Research Area |
Observed Outcome |
| Appetite regulation |
Reduced hunger and improved satiety |
| Food intake |
Lower calorie intake and improved dietary control |
| Body weight |
Progressive weight and fat-loss support over time |
| Metabolic response |
Improved metabolic regulation during weight-loss protocols |
Mixing Protocol
Total strength: 30 mg vial
Recommended reconstitution: 2 mL bacteriostatic water
Final concentration: 15 mg/mL
Administration: Once weekly. Higher ranges must be split evenly into twice-weekly doses.
Dosing format: Traditional insulin syringe dosing
Mixing Instructions
| Step |
Instruction |
| 1 |
Draw 2 mL of bacteriostatic water into a sterile syringe. |
| 2 |
Slowly inject the bacteriostatic water into the vial. |
| 3 |
Allow the vial to settle and dissolve gently. Do not shake aggressively. |
| 4 |
Once fully mixed, the final concentration is 15 mg/mL. |
Dose Reference Table
| Dose (mg) |
Volume (mL) |
Insulin Syringe Units |
Concentration |
| 1.5 mg |
0.10 mL |
10 units |
15 mg/mL |
| 3.0 mg |
0.20 mL |
20 units |
15 mg/mL |
| 4.5 mg |
0.30 mL |
30 units |
15 mg/mL |
| 6.0 mg |
0.40 mL |
40 units |
15 mg/mL |
| 7.5 mg |
0.50 mL |
50 units |
15 mg/mL |
| 9.0 mg |
0.60 mL |
60 units |
15 mg/mL |
Escalated Dose Reference
| Split Dose Format |
Total Dose (mg) |
Total Volume (mL) |
Total Syringe Units |
Concentration |
| 2 × 5.25 mg |
10.5 mg |
0.70 mL total |
70 units total |
15 mg/mL |
| 2 × 6.0 mg |
12.0 mg |
0.80 mL total |
80 units total |
15 mg/mL |
Suggested Dosing Structure
| Phase |
Dose (mg) |
Volume (mL) |
Insulin Syringe Units |
Concentration |
| Weeks 1–4 |
1.5 mg |
0.10 mL |
10 units |
15 mg/mL |
| Weeks 5–8 |
3.0 mg |
0.20 mL |
20 units |
15 mg/mL |
| Weeks 9–12 |
4.5 mg |
0.30 mL |
30 units |
15 mg/mL |
| Weeks 13–16 |
6.0 mg |
0.40 mL |
40 units |
15 mg/mL |
| Maintenance |
7.5 mg |
0.50 mL |
50 units |
15 mg/mL |
Higher Dose Range
| Use Level |
Dose (mg) |
Volume (mL) |
Insulin Syringe Units |
Concentration |
| Higher range |
9.0 mg |
0.60 mL |
60 units |
15 mg/mL |
| Higher range |
10.5 mg |
0.70 mL total |
70 units total |
15 mg/mL |
| Higher range |
12.0 mg |
0.80 mL total |
80 units total |
15 mg/mL |
Expected Outcomes
Retatrutide is used where the objective is stronger appetite control and more reliable fat-loss progress over time.
| Expected Outcome |
Practical Effect |
| Reduced appetite |
Less hunger through the day |
| Improved satiety |
Easier portion control |
| Lower food intake |
Better calorie control |
| Better dietary adherence |
Improved consistency |
| Progressive fat loss |
Ongoing body-composition improvement |
Warnings
| Warning |
Detail |
| Use frequency |
Use once weekly only. At higher ranges, the weekly dose must be split evenly into twice-weekly doses. |
| Dose escalation |
Do not increase the dose if the current dose is not well tolerated. |
| Reconstitution |
Use bacteriostatic water and mix carefully before use. |
| Storage |
Store refrigerated at 2–8°C. |
| Freezing |
Do not freeze. |
Related Products
| Product |
Use Case |
| Bacteriostatic Water |
Required for reconstitution |
| Insulin Syringes |
Required for dosing |
| Tirzepatide Self Mix |
Alternative weight management option |
